Last update 01 Nov 2024
Human Coagulation Factor IX(Guangdong Shuanglin Biological)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Non-recombinant coagulation factor |
Synonyms- |
Target |
Mechanism factor IX modulators(Coagulation factor IX modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Human Coagulation Factor IX(Guangdong Shuanglin Biological)单臂、开放性、多中心临床试验评价人凝血因子Ⅸ治疗中重型血友病B的有效性、安全性以及药代动力学研究
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy, safety, and pharmacokinetics of human coagulation factor IX in the treatment of moderate to severe hemophilia B
100 Clinical Results associated with Human Coagulation Factor IX(Guangdong Shuanglin Biological)
Login to view more data
100 Translational Medicine associated with Human Coagulation Factor IX(Guangdong Shuanglin Biological)
Login to view more data
100 Patents (Medical) associated with Human Coagulation Factor IX(Guangdong Shuanglin Biological)
Login to view more data
100 Deals associated with Human Coagulation Factor IX(Guangdong Shuanglin Biological)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia B | Phase 3 | CN | 19 Jan 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free